Study to Assess the Efficacy and Safety of Simtuzumab (GS-6624) in Adults With Idiopathic Pulmonary Fibrosis (IPF)
Clinical trial NCT01769196 · TERMINATED
Trial details
- NCT number
- NCT01769196
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-31
- Primary completion
- 2016-02-23
- Enrollment
- 544
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.